Rhou, Yoon Ji Jina http://orcid.org/0000-0003-4151-9282
Wang, Che-Jen
Nguyen, Minh
Vanderniet, Joel A.
Munns, Craig F.
Coleman, Hedley
Kim, James
Holmes-Walker, Deborah Jane http://orcid.org/0000-0002-3640-1370
Lim, Lydia
Girgis, Christian M. http://orcid.org/0000-0001-8746-5529
Article History
Received: 7 November 2021
Accepted: 3 December 2021
First Online: 28 January 2022
Declarations
:
: Craig F. Munns has previously been involved in an Amgen-sponsored clinical trial (not related to this manuscript). Christian M. Girgis has received an honorarium from Amgen for educational presentations on romosozumab. Yoon Ji Jina Rhou, Che-Jen Wang, Minh Nguyen, Joel A. Vanderniet, Craig F. Munns, Hedley Coleman, James Kim, Deborah Jane Holmes-Walker, Lydia Lim, and Christian M. Girgis have no other relevant financial or non-financial conflicts of interest to declare.
: Ethics approval was obtained from the Western Sydney Local Health District Human Ethics Committee and procedures followed were in accordance with the ethics standards of the committee and with the Helsinki Declaration. All data was collected as part of the participants' routine clinical management. Informed consent was obtained prior to photographing and the research participant has provided informed consent for publication of the images in Figures 4a and 4b.